The Rise of Delta

The Rise of Delta

Up next

Boos, Rivalries and Records: Inside the 2026 Olympics

In this episode of “The Sunday Daily,” the host Rachel Abrams is joined by her New York Times colleagues Motoko Rich, Shawna Richer and Juliet Macur, who are all covering this year’s Olympic Games. They discuss how the geopolitical climate may or may not be influencing the compet ...  Show more

'The Interview': The Woman at the Center of the French Rape Trial That Shocked the World

Gisèle Pelicot opens up about surviving years of secret abuse and her life today.Thoughts? Email us at theinterview@nytimes.comWatch our show on YouTube: youtube.com/@TheInterviewPodcastFor transcripts and more, visit: nytimes.com/theinterview Subscribe today at nytimes.com/podca ...  Show more

Recommended Episodes

The Dog Days Of Pandemic Summer with Dr. Abdul El-Sayed
What A Day

The U.S. is currently seeing over 100,000 new COVID cases each day on average. It’s the highest number since this February, with hospitalizations and deaths up as well. We spoke to epidemiologist and former Detroit health commissioner Dr. Abdul El-Sayed about the state of the ...

  Show more

Three Guidelines To Understanding The Delta Variant
Short Wave

Delta is quickly becoming the dominant coronavirus variant in multiple countries. The variant has spread so fast because it is more contagious than the variants that came before it. At the same time, the U.S. is equipped with highly effective vaccines. Ed Yong, science writer for ...  Show more

The Race Against Time to Stop the Delta Variant in the Bay
The Bay

Just when there was a palpable sense that everything might be OK, the highly contagious Delta variant of COVID-19 came along. The race to vaccinate more people is now even more urgent; healthcare workers who are seeing more patients say another surge is entirely preventable, if o ...  Show more

EXCLUSIVE: Pfizer CEO Albert Bourla on the Delta Variant, Boosters and Masks Indoors (Part 1)
In the Bubble with Andy Slavitt: Our Shot

Andy gets answers to listeners’ most important questions from Pfizer CEO Albert Bourla in Part 1 of a two-part interview, including how the Pfizer vaccine is holding up against the Delta variant, if we'll need booster shots, the data out of Israel showing waning immunity after si ...  Show more